Teva Pharmaceuticals
TEVA
TEVA
447 hedge funds and large institutions have $5.52B invested in Teva Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 128 increasing their positions, 154 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 154
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
29% less call options, than puts
Call options by funds: $211M | Put options by funds: $298M
Holders
447
Holding in Top 10
4
Calls
$211M
Puts
$298M
Top Buyers
| 1 | +$29.9M | |
| 2 | +$23.5M | |
| 3 | +$22.1M | |
| 4 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$17.5M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$24.2M | |
| 3 | -$13.8M | |
| 4 |
National Pension Service
Jeonju-Si, Jeollabuk-Do,
South Korea
|
-$13.6M |
| 5 |
JP Morgan Chase
New York
|
-$13.5M |